BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11902921)

  • 1. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
    Lee HS; Kim MJ
    J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumaroyl flavonol glycosides from the leaves of Ginkgo biloba.
    Tang Y; Lou F; Wang J; Li Y; Zhuang S
    Phytochemistry; 2001 Dec; 58(8):1251-6. PubMed ID: 11738417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If; Chen J; Chang TK
    Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Applications of two-dimensional liquid chromatography coupled to mass spectrometry for the separation and identification of compounds in ginkgo biloba extracts].
    Chen X; Kong L; Sheng L; Li X; Zou H
    Se Pu; 2005 Jan; 23(1):46-51. PubMed ID: 15881366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
    Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
    Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 8. Kaempferol-3-O-glucosyl(1-2)rhamnoside from Ginkgo biloba and a reappraisal of other gluco(1-2, 1-3 and 1-4)rhamnoside structures.
    Markham KR; Geiger H; Jaggy H
    Phytochemistry; 1992 Mar; 31(3):1009-11. PubMed ID: 1368033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
    Deng F; Zito SW
    J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC-PDA-TOF/MS coupled with multivariate statistical analysis to rapidly analyze and evaluate Ginkgo biloba leaves from different origin.
    Yao X; Zhou G; Tang Y; Guo S; Qian Y; Jin C; Qin Y; Qian D; Duan JA
    Drug Test Anal; 2014 Mar; 6(3):288-94. PubMed ID: 23666896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective growth inhibitor toward human intestinal bacteria derived from Pulsatilla cernua root.
    Lee HS; Beon MS; Kim MK
    J Agric Food Chem; 2001 Oct; 49(10):4656-61. PubMed ID: 11600003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonol glycosides from Mentha lavandulacea.
    El-Desoky SK; El-Ansari MA; El-Negoumy SI
    Fitoterapia; 2001 Jun; 72(5):532-7. PubMed ID: 11429248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK; Chen J; Yeung EY
    Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
    Mohamed MF; Frye RF
    Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
    Chang TK; Chen J; Teng XW
    Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
    Vasseur M; Jean T; DeFeudis FV; Drieu K
    Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of various extracts of Ginkgo biloba on the response of lysosomes to free radicals and to osmotic shock].
    Wattiaux R; Dubois F; Wattiaux-De Coninck S
    Phlebologie; 1990; 43(4):753-61. PubMed ID: 2093934
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver.
    Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M
    Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of bilobalide and ginkgolides from Ginkgo biloba leaves and Ginkgo products using (1)H-NMR.
    Choi YH; Choi HK; Hazekamp A; Bermejo P; Schilder Y; Erkelens C; Verpoorte R
    Chem Pharm Bull (Tokyo); 2003 Feb; 51(2):158-61. PubMed ID: 12576648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.
    Lin H; Guo X; Zhang S; Dial SL; Guo L; Manjanatha MG; Moore MM; Mei N
    Toxicol Sci; 2014 Jun; 139(2):338-49. PubMed ID: 24595819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.